Last Price
128.949
Today's Change
+1.17 (0.91%)
Day's Change
127.44 - 129.59
Trading Volume
94,257
Market Cap
7 Billion
Shares Outstanding
54 Million
Avg Volume
592,452
Avg Price (50 Days)
124.62
Avg Price (200 Days)
103.30
PE Ratio
-40.38
EPS
-3.19
Earnings Announcement
30-Oct-2024
Previous Close
127.78
Open
127.79
Day's Range
127.445 - 129.59
Year Range
59.22 - 136.605
Trading Volume
94,648
1 Day Change
0.81%
5 Day Change
6.35%
1 Month Change
-3.06%
3 Month Change
13.98%
6 Month Change
46.25%
Ytd Change
67.13%
1 Year Change
68.68%
3 Year Change
145.09%
5 Year Change
77.49%
10 Year Change
312.62%
Max Change
312.62%
No result.
Sector: Healthcare - Healthcare
Industry: Medical Devices
Description:
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California.